Researchers at the Hudson Institute of Medical Research have discovered a genetic target for childhood brain cancer and a method to identify patients most likely to benefit from it.
They believe that these findings are a major step toward developing new drugs to treat some of the most difficult-to-treat paediatric cancers.
